174 related articles for article (PubMed ID: 20863215)
1. Effects of atorvastatin on development of peritoneal fibrosis in rats on peritoneal dialysis.
Yeniçerioglu Y; Uzelce O; Akar H; Kolatan E; Yilmaz O; Yenisey C; Sarioglu S; Meteoglu I
Ren Fail; 2010; 32(9):1095-102. PubMed ID: 20863215
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin improves peritoneal sclerosis induced by hypertonic PD solution in rats.
Duman S; Sen S; Sozmen EY; Oreopoulos DG
Int J Artif Organs; 2005 Feb; 28(2):170-6. PubMed ID: 15770605
[TBL] [Abstract][Full Text] [Related]
3. Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion.
Pletinck A; Van Landschoot M; Steppan S; Laukens D; Passlick-Deetjen J; Vanholder R; Van Biesen W
Nephrol Dial Transplant; 2012 Feb; 27(2):548-56. PubMed ID: 21750165
[TBL] [Abstract][Full Text] [Related]
4. What does the dialysate level of matrix metalloproteinase 2 tell us?
Ertilav M; Timur O; Hür E; Bozkurt D; Nar H; Kologlu T; Sen S; Duman S
Adv Perit Dial; 2011; 27():6-10. PubMed ID: 22073820
[TBL] [Abstract][Full Text] [Related]
5. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
[TBL] [Abstract][Full Text] [Related]
6. Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.
Duman S; Bozkurt D; Sipahi S; Sezak M; Ozkan S; Ertilav M; Sen S; Ok E
Adv Perit Dial; 2008; 24():104-10. PubMed ID: 18986012
[TBL] [Abstract][Full Text] [Related]
7. Effect of renin-angiotensin system inhibitors on prevention of peritoneal fibrosis in peritoneal dialysis patients.
Jing S; Kezhou Y; Hong Z; Qun W; Rong W
Nephrology (Carlton); 2010 Feb; 15(1):27-32. PubMed ID: 20377768
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal enalapril ameliorates morphologic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum.
Duman S; Wieczorowska-Tobis K; Styszynski A; Kwiatkowska B; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2004; 20():31-6. PubMed ID: 15384791
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.
Bozkurt D; Taskin H; Sezak M; Biçak S; Sen S; Ok E; Duman S
Adv Perit Dial; 2008; 24():32-8. PubMed ID: 18985998
[TBL] [Abstract][Full Text] [Related]
10. Does endothelin B receptor deficiency ameliorate the induction of peritoneal fibrosis in experimental peritoneal dialysis?
Kalk P; Rückert M; Godes M; von Websky K; Relle K; Neumayer HH; Hocher B; Morgera S
Nephrol Dial Transplant; 2010 May; 25(5):1474-8. PubMed ID: 19945955
[TBL] [Abstract][Full Text] [Related]
11. The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis.
Ferrantelli E; Liappas G; Vila Cuenca M; Keuning ED; Foster TL; Vervloet MG; Lopéz-Cabrera M; Beelen RH
Kidney Int; 2016 Mar; 89(3):625-35. PubMed ID: 26880457
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
13. Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.
Ertilav M; Hur E; Bozkurt D; Sipahi S; Timur O; Sarsik B; Akcicek F; Duman S
Nephrology (Carlton); 2011 Aug; 16(6):552-7. PubMed ID: 21382127
[TBL] [Abstract][Full Text] [Related]
14. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
[TBL] [Abstract][Full Text] [Related]
15. The effects of Panax notoginseng saponins on the cytokines and peritoneal function in rats with peritoneal fibrosis.
Hu W; Zhang Y; Sigdel KR
Ren Fail; 2015; 37(9):1507-13. PubMed ID: 26371362
[TBL] [Abstract][Full Text] [Related]
16. Aliskiren ameliorates chlorhexidine digluconate-induced peritoneal fibrosis in rats.
Ke CY; Lee CC; Lee CJ; Subeq YM; Lee RP; Hsu BG
Eur J Clin Invest; 2010 Apr; 40(4):301-9. PubMed ID: 20486991
[TBL] [Abstract][Full Text] [Related]
17. Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies.
Hung KY; Huang JW; Chiang CK; Tsai TJ
Nephrol Dial Transplant; 2008 Dec; 23(12):3831-40. PubMed ID: 18614818
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin ameliorates tissue damage of obstructed ureter in rats.
Chuang YH; Chuang WL; Huang SP; Liu CK; Huang CH
Life Sci; 2011 Nov; 89(21-22):795-805. PubMed ID: 21971118
[TBL] [Abstract][Full Text] [Related]
19. Role of adhesion molecules in the progression of peritoneal sclerosis.
Imai H; Nakamoto H; Fukushima R; Ishida Y; Yamanouchi Y; Suzuki H
Adv Perit Dial; 2003; 19():180-5. PubMed ID: 14763058
[TBL] [Abstract][Full Text] [Related]
20. Impact of rapamycin on peritoneal fibrosis and transport function.
Xu T; Xie JY; Wang WM; Ren H; Chen N
Blood Purif; 2012; 34(1):48-57. PubMed ID: 22922738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
